Top

BMC Pulmonary Medicine

Published in:

Open Access 01-12-2020 | Hypoxemia | Research article

Chronic hypoxaemia and gender status modulate adiponectin plasmatic level and its multimer proportion in severe COPD patients: new endotypic presentation?

Authors: Mélany Pierard, Alexandra Tassin, Antoine Legrand, Alexandre Legrand

Published in: BMC Pulmonary Medicine | Issue 1/2020

Abstract

Background

Disease progression in COPD patient is associated to lung function decline, leading to a higher risk of hypoxaemia and associated comorbidities, notably cardiovascular diseases (CVD). Adiponectin (Ad) is an adipokine with cardio-protective properties. In COPD patients, conflicting results were previously reported regarding Ad plasmatic (Ad_pl) level, probably because COPD is a heterogeneous disease with multifactorial influence. Among these factors, gender and hypoxaemia could interact in a variety of ways with Ad pathway. Therefore, we postulated that these components could influence Ad_pl level and its multimers in COPD patients and contribute to the appearance of a distinct endotype associated to an altered CVD risk.

Methods

One hundred COPD patients were recruited: 61 were men and 39 were women. Patients who were not severely hypoxemic were allocated to non-hypoxemic group which included 46 patients: 27 men and 19 women. Hypoxemic group included 54 patients: 34 men and 20 women. For all patients, Ad_pl level and proportion of its different forms were measured. Differences between groups were evaluated by Rank-Sum tests. The relationship between these measures and BMI, blood gas analysis (PaO₂, PaCO₂), or lung function (FEV1, FEV1/FVC, TL_CO, TLC, RV) were evaluated by Pearson correlation analysis.

Results

Despite similar age, BMI and obstruction severity, women had a higher TLC and RV (median: TLC = 105%; RV = 166%) than men (median: TLC = 87%; RV = 132%). Ad_pl level was higher in women (median = 11,152 ng/ml) than in men (median = 10,239 ng/ml) and was negatively associated with hyperinflation (R = − 0,43) and hypercapnia (R = − 0,42). The proportion of the most active forms of Ad (HMW) was increased in hypoxemic women (median = 10%) compared with non-hypoxemic women (median = 8%) but was not modulated in men.

Conclusion

COPD pathophysiology seemed to be different in hypoxemic women and was associated to Ad modulations. Hyperinflation and air-trapping in association with hypercapnia and hypoxaemia, could contribute to a modulation of Ad_pl level and of its HMW forms. These results suggest the development of a distinct endotypic presentation, based on gender.

Available only for authorised users

Kent BD, Mitchell PD, McNicholas WT. Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis. 2011;6:199–208.PubMedPubMedCentral

Maclay JD, McAllister DA, Macnee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology. 2007;12(5):634–41.PubMedCrossRef

Kamil F, Pinzon I, Foreman MG. Sex and race factors in early-onset COPD. Curr Opin Pulm Med. 2013;19(2):140–4.PubMedPubMedCentralCrossRef

Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, et al. Gender and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176(12):1179–84.PubMedPubMedCentralCrossRef

Raherison C, Biron E, Nocent-Ejnaini C, Taillé C, Tillie-Leblond I, Prudhomme A. Are there specific characteristics of COPD in women? Rev Mal Respir. 2010;27(6):611–24.PubMedCrossRef

Kanner RE, Connett JE, Altose MD, Buist AS, Lee WW, Tashkin DP, et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The lung health study. Am J Respir Crit Care Med. 1994;150(4):956–61.PubMedCrossRef

Amaral AFS, Strachan DP, Burney PGJ, Jarvis DL. Female smokers are at greater risk of airflow obstruction than male smokers. UK biobank. Am J Respir Crit Care Med. 2017;195(9):1226–35.PubMedCrossRef

Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645–53.PubMedCrossRef

Sayiner A, Hague C, Ajlan A, Leipsic J, Wierenga L, Krowchuk NM, et al. Bronchiolitis in young female smokers. Respir Med. 2013;107(5):732–8.PubMedCrossRef

10.

Sawalha S, Hedman L, Backman H, Stenfors N, Rönmark E, Lundbäck B, et al. The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study. Ther Adv Respir Dis. 2019;13:1753466619860058.PubMedPubMedCentralCrossRef

11.

Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116(7):1784–92.PubMedPubMedCentralCrossRef

12.

Swarbrick MM, Havel PJ. Physiological, pharmacological, and nutritional regulation of circulating Adiponectin concentrations in humans. Metab Syndr Relat Disord. 2008;6(2):87–102.PubMedPubMedCentralCrossRef

13.

Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes. 2006;55(1):249–59.PubMedCrossRef

14.

Yamauchi T, Kadowaki T. Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab. 2013;17(2):185–96.PubMedCrossRef

15.

Ebrahimi-Mamaeghani M, Mohammadi S, Arefhosseini SR, Fallah P, Bazi Z. Adiponectin as a potential biomarker of vascular disease. Vasc Health Risk Manag. 2015;11:55–70.PubMedPubMedCentral

16.

Xie J, Yang X-Y, Shi J-D, Deng X-Q, Long W. A new inflammation marker of chronic obstructive pulmonary disease-adiponectin. World J Emerg Med. 2010;1(3):190–5.PubMedPubMedCentral

17.

Uzum AK, Aydin MM, Tutuncu Y, Omer B, Kiyan E, Alagol F. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight chronic obstructive pulmonary disease patients. Eur J Intern Med. 2014;25(4):364–9.PubMedCrossRef

18.

Breyer M-K, Rutten EPA, Locantore NW, Watkins ML, Miller BE, Wouters EFM, et al. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease. Eur J Clin Invest. 2012;42(9):983–91.PubMedCrossRef

19.

Bianco A, Nigro E, Monaco ML, Matera MG, Scudiero O, Mazzarella G, et al. The burden of obesity in asthma and COPD: role of adiponectin. Pulm Pharmacol Ther. 2017;43:20–5.PubMedCrossRef

20.

Jaswal S, Saini V, Kaur J, Gupta S, Kaur H, Garg K. Association of adiponectin with lung function impairment and disease severity in chronic obstructive pulmonary disease. Int J Appl Basic Med Res. 2018;8(1):14.PubMedPubMedCentralCrossRef

21.

Rubinsztajn R, Przybyłowski T, Maskey-Warzęchowska M, Paplińska-Goryca M, Karwat K, Nejman-Gryz P, et al. Correlation between hyperinflation defined as an elevated RV/TLC ratio and body composition and cytokine profile in patients with chronic obstructive pulmonary disease. Pneumonol Alergol Pol. 2015;83(2):120–5.PubMedCrossRef

22.

Wert SE. Does adiponectin play a role in pulmonary emphysema? Am J Physiol Lung Cell Mol Physiol. 2008;294(6):L1032–4.PubMedCrossRef

23.

Guo Q, Jin S, Hu H, Zhou Y, Yan Y, Zong H, et al. Hypoxia in 3T3-L1 adipocytes suppresses adiponectin expression via the PERK and IRE1 unfolded protein response. Biochem Biophys Res Commun. 2017;493(1):346–51.PubMedCrossRef

24.

Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of Ob/Ob and dietary obese mice. Am J Physiol Endocrinol Metab. 2007;293(4):E1118–28.PubMedCrossRef

25.

Pan G, Su M, Ding W, Ding N, Huang H, Zhang X. Effects of chronic intermittent hypoxia on oxidative stress and inflammatory response and the interventional roles of adiponectin. Zhonghua Yi Xue Za Zhi. 2015;95(16):1218–21.PubMed

26.

Sato K, Shibata Y, Abe S, Inoue S, Igarashi A, Yamauchi K, et al. Association between plasma adiponectin levels and decline in forced expiratory volume in 1 s in a general Japanese population: the Takahata study. Int J Med Sci. 2014;11(8):758–64.PubMedPubMedCentralCrossRef

27.

Barrecheguren M, Miravitlles M. COPD heterogeneity: implications for management. Multidiscip Respir Med. 2016;11 [cited 2020 Jun 18]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794904/.

28.

Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179–91.PubMedCrossRef

29.

Global Initiative for Chronic Obstructive Lung Disease. Gold Reports 2020. 2020 [cited 2020 Jun 19]. Available from: https://goldcopd.org/gold-reports/.

30.

Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CPM, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26(4):720–35.PubMedCrossRef

31.

Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511–22.PubMedCrossRef

32.

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.PubMedCrossRef

33.

Pierard M, Conotte S, Tassin A, Boutry S, Uzureau P, Boudjeltia KZ, et al. Interactions of exercise training and high-fat diet on adiponectin forms and muscle receptors in mice. Nutr Metab (Lond). 2016;13 [cited 2017 Jun 22]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094086/.

34.

Pierard M, Tassin A, Conotte S, Zouaoui Boudjeltia K, Legrand A. Sustained intermittent hypoxemia induces Adiponectin oligomers redistribution and a tissue-specific modulation of Adiponectin receptor in mice. Front Physiol. 2019;10 [cited 2019 Feb 13]. Available from: https://www.frontiersin.org/articles/10.3389/fphys.2019.00068/full.

35.

Song HJ, Oh S, Quan S, Ryu O-H, Jeong J-Y, Hong K-S, et al. Gender differences in adiponectin levels and body composition in older adults: Hallym aging study. BMC Geriatr. 2014;14:8.PubMedPubMedCentralCrossRef

36.

Eglit T, Lember M, Ringmets I, Rajasalu T. Gender differences in serum high-molecular-weight adiponectin levels in metabolic syndrome. Eur J Endocrinol. 2013;168(3):385–91.PubMedCrossRef

37.

Sun Y, Xun K, Wang C, Zhao H, Bi H, Chen X, et al. Adiponectin, an unlocking adipocytokine. Cardiovasc Ther. 2009;27(1):59–75.PubMedCrossRef

38.

Breyer M-K, Rutten EPA, Vernooy JHJ, Spruit MA, Dentener MA, van der Kallen C, et al. Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin. Respir Med. 2011;105(7):1046–53.PubMedCrossRef

39.

Frederiksen L, Højlund K, Hougaard DM, Mosbech TH, Larsen R, Flyvbjerg A, et al. Testosterone therapy decreases subcutaneous fat and adiponectin in aging men. Eur J Endocrinol. 2012;166(3):469–76.PubMedCrossRef

40.

Horenburg S, Fischer-Posovszky P, Debatin K-M, Wabitsch M. Influence of sex hormones on adiponectin expression in human adipocytes. Horm Metab Res. 2008;40(11):779–86.PubMedCrossRef

41.

Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002;51(9):2734–41.PubMedCrossRef

42.

Page ST, Herbst KL, Amory JK, Coviello AD, Anawalt BD, Matsumoto AM, et al. Testosterone administration suppresses adiponectin levels in men. J Androl. 2005;26(1):85–92.PubMed

43.

Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med. 2009;6(Suppl 1):60–75.PubMedPubMedCentralCrossRef

44.

Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007;380(1–2):24–30.PubMedPubMedCentralCrossRef

45.

Casimir GJ, Heldenbergh F, Hanssens L, Mulier S, Heinrichs C, Lefevre N, et al. Gender differences and inflammation: an in vitro model of blood cells stimulation in prepubescent children. J Inflamm (Lond). 2010;7:28.CrossRef

46.

Rathod K, Kapil V, Velmurugan S, Khambata R, Siddique U, Khan S, et al. Sex differences in the inflammatory response and inflammation-induced vascular dysfunction. Lancet. 2017;389:S20.CrossRef

47.

Diodato MD, Knöferl MW, Schwacha MG, Bland KI, Chaudry IH. Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis. Cytokine. 2001;14(3):162–9.PubMedCrossRef

48.

Zein JG, Erzurum SC. Asthma is different in women. Curr Allergy Asthma Rep. 2015;15(6):28.PubMedPubMedCentralCrossRef

49.

Fuseini H, Newcomb DC. Mechanisms driving gender differences in asthma. Curr Allergy Asthma Rep. 2017;17(3):19.PubMedPubMedCentralCrossRef

50.

Postma DS. Gender differences in asthma development and progression. Gend Med. 2007;4 Suppl B:S133–46.PubMedCrossRef

51.

Xu L, Bao H-G, Si Y-N, Han L, Zhang R, Cai M-M, et al. Effects of adiponectin on acute lung injury in cecal ligation and puncture-induced sepsis rats. J Surg Res. 2013;183(2):752–9.PubMedCrossRef

52.

Borel J, Roux-Lombard P, Tamisier R, Arnaud C, Monneret D, Arnol N, et al. Endothelial dysfunction and specific systemic inflammation in obesity hypoventilation syndrome. In: C20 endothelial dysfunction and beyond in sleep disordered breathing: American Thoracic Society; 2009. p. A3983. [cited 2018 Oct 3]. (American Thoracic Society International Conference Abstracts). Available from: https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2009.179.1_MeetingAbstracts.A3983.

53.

Dimoulis A, Pastaka C, Tsolaki V, Tsilioni I, Pournaras S, Liakos N, et al. Non-invasive ventilation (NIV) and homeostatic model assessment (HOMA) index in stable chronic obstructive pulmonary disease (COPD) patients with chronic Hypercapnic respiratory failure: a pilot study. COPD. 2015;12(4):427–34.PubMedCrossRef

54.

Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J. 2004;68(11):975–81.PubMedCrossRef

55.

Van Berendoncks AM, Garnier A, Beckers P, Hoymans VY, Possemiers N, Fortin D, et al. Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Circ Heart Fail. 2010;3(2):185–94.PubMedCrossRef

56.

Li R, Xu M, Wang X, Wang Y, Lau WB, Yuan Y, et al. Reduced vascular responsiveness to adiponectin in hyperlipidemic rats--mechanisms and significance. J Mol Cell Cardiol. 2010;49(3):508–15.PubMedPubMedCentralCrossRef

57.

Spitzer JA, Zhang P. Gender differences in neutrophil function and cytokine-induced neutrophil chemoattractant generation in endotoxic rats. Inflammation. 1996;20(5):485–98.PubMedCrossRef

58.

Casimir GJA, Duchateau J. Gender differences in inflammatory processes could explain poorer prognosis for males. J Clin Microbiol. 2011;49(1):478–9.PubMedPubMedCentralCrossRef

59.

Onat A, Karadeniz Y, Tusun E, Yüksel H, Kaya A. Advances in understanding gender difference in cardiometabolic disease risk. Expert Rev Cardiovasc Ther. 2016;14(4):513–23.PubMedCrossRef

60.

Verhage TL, Heijdra Y, Molema J, Vercoulen J, Dekhuijzen R. Associations of muscle depletion with health status. Another gender difference in COPD? Clin Nutr. 2011;30(3):332–8.PubMedCrossRef

61.

Grabicki M, Kuźnar-Kamińska B, Rubinsztajn R, Brajer-Luftmann B, Kosacka M, Nowicka A, et al. COPD course and comorbidities: are there gender differences? Adv Exp Med Biol. 2019;1113:43–51.

62.

Laviolette L, Lacasse Y, Doucet M, Lacasse M, Marquis K, Saey D, et al. Chronic obstructive pulmonary disease in women. Can Respir J. 2007;14(2):93–8.PubMedPubMedCentralCrossRef

63.

Shade D, Cordova F, Lando Y, Travaline JM, Furukawa S, Kuzma AM, et al. Relationship between resting hypercapnia and physiologic parameters before and after lung volume reduction surgery in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(5 Pt 1):1405–11.PubMedCrossRef

64.

Camp PG, Coxson HO, Levy RD, Pillai SG, Anderson W, Vestbo J, et al. Sex differences in emphysema and airway disease in smokers. Chest. 2009;136(6):1480–8.PubMedCrossRef

65.

Dransfield MT, Washko GR, Foreman MG, Estepar RSJ, Reilly J, Bailey WC. Gender differences in the severity of CT emphysema in COPD. Chest. 2007;132(2):464–70.PubMedCrossRef

66.

Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Weinmann G, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med. 2007;176(3):243–52.PubMedPubMedCentralCrossRef

67.

Hardin M, Foreman M, Dransfield MT, Hansel N, Han MK, Cho MH, et al. Sex-specific features of emphysema among current and former smokers with COPD. Eur Respir J. 2016;47(1):104–12.PubMedCrossRef

68.

Lin Y-H, Jiang T-X, Hu S-X, Shi Y-H. Association between serum adiponectin concentrations and chronic obstructive pulmonary disease: a meta-analysis. Biosci Rep. 2020;40(3) [cited 2020 Apr 29]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069907/.

Title: Chronic hypoxaemia and gender status modulate adiponectin plasmatic level and its multimer proportion in severe COPD patients: new endotypic presentation?
Authors: Mélany Pierard
Alexandra Tassin
Antoine Legrand
Alexandre Legrand
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Hypoxemia
Chronic Obstructive Lung Disease
Published in: BMC Pulmonary Medicine / Issue 1/2020
Electronic ISSN: 1471-2466
DOI: https://doi.org/10.1186/s12890-020-01288-3

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Chronic hypoxaemia and gender status modulate adiponectin plasmatic level and its multimer proportion in severe COPD patients: new endotypic presentation?

Abstract

Background

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2020

Polymorphisms in the airway epithelium related genes CDHR3 and EMSY are associated with asthma susceptibility

Assessment of viral RNA in idiopathic pulmonary fibrosis using RNA-seq

Concordance for changes in allergic asthma domain variables after short-term corticosteroid therapy

Respiratory viruses in mechanically ventilated patients: a pilot study

Development and outcomes of a comprehensive multidisciplinary incidental lung nodule and lung cancer screening program

Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3)

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page